Arcoxia,
etoricoxib,
L 791456,
L-791456,
L791456,
MK 0663,
MK-0663,
MK0663,
Etoricoxib,
202409-33-4,
Arcoxia,
Algix,
Tauxib,
Nucoxia,
MK-0663,
MK-663,
5-Chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-2,3'-bipyridine,
MK 0663,
Etoricoxib [USAN:INN:BAN],
UNII-WRX4NFY03R,
L-791456,
MK 663,
5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine,
MK0663,
WRX4NFY03R,
L791456,
5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine,
CHEBI:6339,
CHEMBL416146,
MNJVRJDLRVPLFE-UHFFFAOYSA-N,
5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine,
NCGC00164578-01,
Etoricoxibe,
AK115816,
Etropain,
Torcoxia,
Etoxib,
2,3'-Bipyridine, 5-chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-,
2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-,
DSSTox_CID_26457,
DSSTox_RID_81631,
DSSTox_GSID_46457,
Kingcox,
5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl,
5-chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine,
CAS-202409-33-4,
SR-05000001486,
Etoricoxib (USAN/INN),
etoricoxibum,
AC1L3WZM,
SCHEMBL4680,
GTPL2896,
DTXSID3046457,
CTK8E8328,
HMS2090A05,
HMS3713P20,
ZINC579472,
BCP06428,
EX-A2642,
KS-00000G8U,
Tox21 112206,
Tox21_112206,
BDBM50072064,
Etoricoxib; MK-663; MK-0663,
MFCD06797512,
s4651,
AKOS016010125,
Tox21_112206_1,
API0002661,
CCG-220639,
CS-1047,
DB01628,
RTC-030142,
SB18988,
NCGC00164578-02,
5CH,
AC-29052,
AJ-23602,
AN-16569,
AS-17761,
CC-28334,
HY-15321,
ZB014476,
AB0020709,
AX8129880,
LS-181802,
TC-030142,
FT-0082494,
FT-0602793,
ST24044654,
V1697,
C11718,
D03710,
Etoricoxib, VETRANAL(TM), analytical standard,
W-5339,
AB01275483-01,
409E334,
C-20862,
L001141,
J-013140,
SR-05000001486-1,
SR-05000001486-2,
BRD-K54770957-001-01-9,
BRD-K54770957-001-02-7,
F2173-0490,
Etoricoxib, United States Pharmacopeia (USP) Reference Standard,
5-chloro-2-(6-methyl-3-pyridyl)-3-(4-methylsulfonylphenyl)pyridine,
5-Chloro-6'-methyl-3-(4-(methylsulfonyl)-phenyl)-2,3'-bipyridine,
5-Chloro-3-(4-methanesulfonyl-phenyl)-6''''-methyl-[2,3'''']bipyridinyl,
5-Chloro-3-(4-methanesulfonyl-phenyl)-6''-methyl-[2,3'']bipyridinyl,
5-chloro-3-(4-methanesulfonylphenyl)-2-(6-methylpyridin-3-yl)pyridine,
5-Chloro-3-[4-(methylsulfonyl)phenyl]-2-(2-methyl-5-pyridinyl)pyridine,
5-chloro-6''-methyl-3-[4-(methylsulfonyl)phenyl]-2,3''-bipyridine,
etobrix,
etocox,
Etoricoxib-d3,
Arcoxia (TN),
Etoricoxib [USAN],
Tauxib (TN),
Algix (TN),
D09MGR,
C18H15ClN2O2S,
Etoricoxib, 98% - 1G 1g,
C18-H15-Cl-N2-O2-S,
CID123619,
ACN-037621,
CS-O-10073,
Merck Sharp & Dohme brand of etoricoxib,
A3405,
A13770,
C422649,
L 791456,
D000077613,
2,3'-bipiridina, 5-cloro-6'-metil-3-[4-(metilsulfonil)fenil]-,
5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2 3'-bipyridine,
5-chloro-3-(4-methylsulfonyl)phenyl-2-(2-methyl-5-pyridinyl)pyridine,
2,?3'-?Bipyridine, 5-?chloro-?6'-?methyl-?3-?[4-?(methylsulfonyl)?phenyl]?-,
850896-71-8,